Tradestie Institutional Equity Comparison Engine

IBIO vs AYTU โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AYTU Overall Edge

AYTU Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AYTU BioPharma, Inc. Common Stock (AYTU) driven by superior Valuation, Momentum & Technical while IBIO counters with relative strength in Growth & Margin. Fundamentally, IBIO trades at N/M Forward P/E with -3025.6% operating margin (+975.0% YoY revenue) versus AYTU at 9.2x Forward P/E and -14.4% operating margin (+6.4% YoY). In options structure, IBIO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AYTU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner AYTU
IBIO N/M vs AYTU 9.2x Fwd P/E
Growth & Margin Winner IBIO
Op Margin -3025.6% vs -14.4% ยท YoY +975.0% vs +6.4%
Momentum & Technical Winner AYTU
1Y -37.7% vs -12.1% ยท 52W Pos 1% vs 5%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
IBIO NASDAQ
iBio, Inc. Common Stock
Pharmaceutical Preparations
$0.72
-2.04% 1D
Market Cap $53.7M
1M Return -6.46%
1Y Return -37.67%
Forward P/E N/M
Unified AI Score
46.0 / 100 HOLD
Tech 45.0 Fund 46.0 Flow 50.0 Mom 64.0
AYTU NASDAQ
AYTU BioPharma, Inc. Common Stock
Pharmaceutical Preparations
$1.81
+1.69% 1D
Market Cap $19.6M
1M Return -11.27%
1Y Return -12.14%
Forward P/E 9.2x
Unified AI Score
48.9 / 100 HOLD
Tech 49.0 Fund 53.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IBIO -37.67% AYTU -12.14% Spread: +25.53 pp (AYTU Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period IBIO Revenue AYTU Revenue IBIO Op. Margin AYTU Op. Margin Margin Edge
FY2019 $0M $10M -782.4% -230.1% AYTU
FY2020 $0M $30M -854.9% -76.5% AYTU
FY2021 $0M $70M -1312.1% -89.7% AYTU
FY2022 $0M $100M -1576.3% -113.7% AYTU
FY2023 N/A $110M N/A -15.9% AYTU
FY2024 $0M $70M -7392.9% -2.4% AYTU
FY2025 $0M $70M -4650.5% -11.8% AYTU
FY2026 $0M $60M -35141.0% -14.4% AYTU

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IBIO (4) vs AYTU (6)
Institutional Metric IBIO AYTU Criterion Row Winner
Market Capitalization Scale $53.7M $19.6M Larger Scale IBIO
Trailing P/E Ratio Valuation N/M 9.2x Lower Multiple AYTU
Forward P/E Ratio Valuation N/M 9.2x Lower Multiple AYTU
Revenue Growth (YoY) Growth +975.0% +6.4% Higher Growth IBIO
Operating Margin (TTM) Profitability -3025.6% -14.4% Higher Margin AYTU
Net Profit Margin Profitability 0.0% -24.8% Higher Margin IBIO
Return on Equity (ROE) Capital Efficiency -51.8% -52.5% Higher ROE IBIO
52-Week Range Position Momentum 1% ($1โ€“$4) 5% ($2โ€“$3) Stronger Trend AYTU
Beta / 30D Volatility Risk Regime 2.07ฮฒ ยท 89% Vol 0.65ฮฒ ยท 35% Vol Lower Realized Risk AYTU
Unified Institutional Score Composite Signal 46.0 / 100 (HOLD) 48.9 / 100 (HOLD) Higher Composite AYTU

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IBIO vs AYTU Buy Guide
IBIO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live IBIO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AYTU UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AYTU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IBIO nor AYTU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.